Cell Guidance Systems is developing a patented technology to unlock the medical potential of growth factor proteins. PODS enables proteins to treat diseases, such as Parkinson's disease and osteoarthritis, by improving their delivery to the disease site. The technology addresses multi-$bn markets.
2019 | 2020 | |
---|---|---|
Turnover | - | - |
Cash | £260.08k | £282.46k |
Increase in Cash | - | - |
Financial data drawn from last filed accounts don't necessarily reflect current trading activity.